Tag: COVID-19
-
CDC Recommendation Regarding Mask Use on Public Transportation
At CDC’s recommendation, TSA will extend the security directive for mask use on public transportation and transportation hubs for one month, through April 18th. During that time, CDC will work with government agencies to help inform a revised policy framework for when, and under what circumstances, masks should be required in the public transportation corridor.…
-
NASA TV to Air NOAA’s GOES-T Launch, Prelaunch Activities
NASA will provide coverage of the prelaunch and launch activities of the National Oceanic and Atmospheric Administration’s (NOAA) next weather observing and environmental monitoring system satellite. Currently known as GOES-T, this is the third satellite in NOAA’s Geostationary Operational Environmental Satellites (GOES) – R series. GOES-T is scheduled to launch at 4:38 p.m. EST Tuesday,…
-
What You Need to Know about Omicron
Omicron in the United States CDC is working with state and local public health officials to monitor the spread of Omicron. As of December 20, 2021, Omicron had been detected in most states and territories and continues to be the dominant variant in the United States. What We Know about Omicron CDC has been collaborating with…
-
A potential at-home COVID-19 test is just as good as laboratory PCR tests, according to preclinical data
More research needed to validate test Researchers at the University of Illinois Chicago have designed a high-quality assay that can be used in at-home tests for rapid COVID-19 screening. Results from an early preclinical study suggest that tests with the new assay may be just as reliable as the laboratory-based molecular tests — called PCR tests — used by hospitals…
-
NASA Commits $28 Million to Underfunded US Jurisdictions
NASA has awarded $28 million to fund the next five years of research infrastructure development across 28 jurisdictions. The Established Program to Stimulate Competitive Research (EPSCoR), a part of NASA’s Office of Stem Engagement and based out of the agency’s Kennedy Space Center in Florida, supports science and technology research and development at colleges and…
-
Are We Close to a Pill to Treat Covid? (video)
Scientist are racing to develop new tools to combat and treat COVID-19. One of those tools is an experimental pill to treat the pandemic. Merck is the first company to seek emergency us authorization from the FDA with its molnupiravir, an antiviral pill which, once approved, will become a valuable tool in the fight to…
-
ACT−Accelerator partnership welcomes leadership and commitments at US COVID Summit to ending COVID−19 pandemic through equitable access to tests, treatments, and vaccines
President Biden and global leaders agreed ambitious targets, aligned with the ACT-Accelerator, to end the COVID-19 pandemic Collective accountability for world leaders, industry and partners emphasized, as global response now turns to implementation of these targets Concrete action must now follow this summit to deliver and deploy tests, treatments, and vaccines immediately, to prevent further…
-
Phoenix City Council Approves Public Transit Resources for the Most Vulnerable
The Phoenix city council voted unanimously today to approve $1 million to help residents in need with the cost of riding public transit. The city will use federal American Rescue Plan Act (ARPA) funds to purchase more than 31,000 monthly transit passes. The move significantly increases the number of reduced-fare passes for those passengers…
-
FDA Approves First COVID-19 Vaccine
Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization…
-
Rigel Pharmaceuticals Provides Update on COVID-19 Program
SOUTH SAN FRANCISCO, Calif. — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that clinical data submitted in late-May from a 59-patient NIH/NHLBI-sponsored Phase 2 trial of fostamatinib to treat hospitalized patients suffering from COVID-19 are insufficient for an emergency use authorization (EUA) at this time.…